Literature DB >> 11554012

Inflammation in Parkinson's disease.

P L McGeer1, K Yasojima, E G McGeer.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11554012

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  51 in total

Review 1.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

2.  Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.

Authors:  Bin Xing; Tao Xin; Lingling Zhao; Randy L Hunter; Yan Chen; Guoying Bing
Journal:  J Neuroimmunol       Date:  2010-05-14       Impact factor: 3.478

Review 3.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

Review 4.  c-Abl in neurodegenerative disease.

Authors:  Sarah D Schlatterer; Christopher M Acker; Peter Davies
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

5.  Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells.

Authors:  Zarah Batulan; Josephine Nalbantoglu; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

6.  Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients.

Authors:  Grazia Maria Liuzzi; Tiziana Latronico; Maria Teresa Branà; Pasqua Gramegna; Maria Gabriella Coniglio; Rocco Rossano; Marilena Larocca; Paolo Riccio
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

Review 7.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

8.  Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats.

Authors:  Randy L Hunter; Dong-Young Choi; Stuart A Ross; Guoying Bing
Journal:  Neurosci Lett       Date:  2008-01-22       Impact factor: 3.046

9.  NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.

Authors:  Liya Qin; Yuxin Liu; Jau-Shyong Hong; Fulton T Crews
Journal:  Glia       Date:  2013-03-28       Impact factor: 7.452

Review 10.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.